EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Treatment of acute COVID-19 in the community

Eliza Milliken iD

Australian Prescriber · 04.08.2026 · 49 (4) · 116-123

DOI: 10.18773/austprescr.2026.033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Australian Prescriber, online erschienen am 04.08.2026. Verfasst von Eliza Milliken. Beteiligte Einrichtung: Hunter New England Health, New South Wales. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 infection in an otherwise healthy person is usually a mild to moderate self-limiting illness, but certain populations are at higher risk of severe disease (e.g. older age, severe immunocompromise, certain comorbidities). Adults with acute COVID-19 should be assessed for disease severity and underlying risk factors to guide appropriate management. Infection control, including case isolation, is important to reduce spread. Antiviral therapy is reserved for patients most likely to benefit, given its high cost, potential adverse effects and uncertain clinical benefit. Patients showing signs of severe or critical disease should be referred to hospital. Antiviral therapies are most effective when started within 5 days of symptom onset. Nirmatrelvir with ritonavir is the first-line antiviral for patients without contraindications, but it has extensive drug interactions. Molnupiravir is used when nirmatrelvir with ritonavir is unsuitable. Inhaled and oral glucocorticoids and immune therapies have no role in routine community treatment of mild to moderate COVID-19. Vaccination remains the single most effective intervention for reducing the risk of severe disease and should be actively encouraged, particularly in unvaccinated or vaccine-hesitant individuals.

Schlagwörter

Stichwörter der Autor:innen

COVID-19SARS-CoV-2 infectionantiviralsmolnupiravirnirmatrelvirritonavir

Autor:innen und Institutionen

  • Hunter New England Health, New South Wales.

ORCID-Profile: Eliza Milliken

Zitieren

APA

Milliken, E. (2026). Treatment of acute COVID-19 in the community. Australian Prescriber, 49(4), 116-123. https://doi.org/10.18773/austprescr.2026.033

Vancouver

Milliken E. Treatment of acute COVID-19 in the community. Australian Prescriber. 2026;49(4):116-123. doi:10.18773/austprescr.2026.033

BibTeX
@article{Milliken2026,
  author = {Milliken, Eliza},
  title = {Treatment of acute COVID-19 in the community},
  journal = {Australian Prescriber},
  year = {2026},
  volume = {49},
  number = {4},
  pages = {116--123},
  doi = {10.18773/austprescr.2026.033}
}
Kostenlos starten →